MedPath

Study of Venusia® Max Cream as Moisturizer in Psoriasis

Not Applicable
Completed
Conditions
Health Condition 1: null- Psoriasis
Registration Number
CTRI/2017/03/008023
Lead Sponsor
Dr Reddys Laboratories Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
400
Inclusion Criteria

1.Patients with psoriasis who have been prescribed Venusia® Max cream

2.Patients of both sexes, aged 18 years to 75 years who provide informed consent for data collection

Exclusion Criteria

1.Those with known hypersensitivity to any ingredient of Venusia® Max cream

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
�Effectiveness of Venusia® Max cream in improving Quality of Life, as recorded using Dermatology Life Quality Index (DLQI) Questionnaire, at 4 weeks compared to baselineTimepoint: Baseline and 4 weeks
Secondary Outcome Measures
NameTimeMethod
�Effectiveness of Venusia® Max cream in improvement of severity of dryness, as recorded using the Dry skin/ichthyosis Area and Severity Index (DASI) score, at 4 weeks compared to baselineTimepoint: Baseline and 4 weeks
© Copyright 2025. All Rights Reserved by MedPath